Correspondence fc287@medschl.cam.ac.uk In Brief Kieckbusch et al. show that a key leukocyte signaling molecule, p110d, regulates uterine immune cells. Genetic p110d inactivation in mice reduced NK but increased macrophage function, thus impeding uterine arterial remodeling and enhancing local inflammation during pregnancy. Imbalanced adaptation of maternal immune cells curtailed fetal development and increased perinatal morbidity.
INTRODUCTION
Class I phosphoinositide 3-kinases (PI3K) convert phosphatidylinositol-(4,5)-phosphate to phosphatidylinositol-(3,4,5)-phosphate (PIP 3 ). PIP 3 acts as a second messenger by recruiting proteins to the plasma membrane, where they activate signaling pathways that promote proliferation, survival, differentiation, and chemotaxis (Okkenhaug, 2013) . PI3K can be subdivided into class I A and I B based on structural similarity. Class I A PI3K form heterodimers of p85 regulatory subunits and one of three isoforms of the catalytical p110 subunit (p110a, p110b, and p110d). While p110a and p110b are ubiquitously expressed, in mice, p110d expression is low or absent in most cell types but high in leukocytes (Vanhaesebroeck et al., 1997) .
PI3K p110d is a key mediator of natural killer (NK) cell maturation and function, and absence of p110d signaling leads to reduced cytokine release, aberrant maturation, and incorrect trafficking to peripheral organs, including the uterus during pregnancy (Guo et al., 2008; Kim et al., 2007; Saudemont et al., 2009; Tassi et al., 2007) . In macrophages and other myeloid cells, the PI3K pathway has two opposing roles. While it promotes tissue infiltration and signal transduction for cytokine secretion in the early phases of inflammation, PI3K signaling also provides negative feedback inhibition and is thus involved in the resolution of inflammation and the prevention of ''collateral damage'' (Fukao and Koyasu, 2003; G€ unzl et al., 2010) . As a result, inactivation of p110d leads to enhanced responses downstream of Toll-like receptors (Aksoy et al., 2012; Uno et al., 2010) , increased production of pro-inflammatory cytokines such as interleukin-6 (IL-6) (Liu et al., 2009 ), upregulation of macrophage activation markers such as CD86 and major histocompatibility complex (MHC) class II in vitro, and chronic inflammation (Uno et al., 2010) . Conversely, deletion of PTEN, which acts antagonistically to the PI3K pathway by degrading PIP 3 , diminishes macrophage inflammatory responses (Sahin et al., 2014) .
In mice, blastocyst implantation provokes a localized, progesterone-driven tissue reaction that causes stromal cells to proliferate extensively and form decidual cells (decidualization) (Dey et al., 2004) . While the decidua grows, the vasculature feeding toward the developing fetoplacental unit changes from its conventional, arterial phenotype characterized by a thick smooth muscle wall to high-capacity, low-resistance vessels. Both processes are disrupted in mice lacking either NK cells (Ashkar et al., 2000; Barber and Pollard, 2003) or interferon-g (IFN-g) signaling (Ashkar and Croy, 1999) , establishing a key role for IFN-g produced by uterine NK (uNK) cells in reproduction. Uterine macrophages are a specialized myeloid subset whose spatial distribution and population dynamics are regulated by local colony stimulating factor (CSF)-1 signaling: macrophages and CSF-1 are highly abundant in the myometrium but relatively sparse in the decidua (Collins et al., 2009; Tagliani et al., 2011) . CSF-1 signaling also blocks macrophage maturation at the transition from MHC class II low to MHC class II high cells (Tagliani et al., 2011) . Little is known about the endogenous cues that activate or inhibit uterine macrophages, but excessive activation by exogenous stimuli is usually prevented (Erlebacher, 2013) . Unrestrained macrophage activation can result in fetal mortality (Haddad et al., 1995; Robertson et al., 2006) . The selective expression of p110d in leukocytes has made it an attractive pharmacological target to treat hematological malignancies and reduce unwanted immune responses in the context of autoimmunity and allergy (Rodon et al., 2013) . Maternal immune adaptations during pregnancy are instrumental for the development of the growing fetus (Erlebacher, 2013; Moffett and Colucci, 2014) . We used transgenic knockin mice carrying a kinase-dead point mutation in the gene coding for p110d (d D910A ) as a genetic model for inactivation of the p110d pathway in order to investigate the effects of unbalanced maternal immune responses during gestation. We show that maternal p110d signaling is required for the normal production of IFN-g in the gravid uterus and the associated NK-driven remodeling of the maternal vasculature feeding toward the fetoplacental unit. Fetuses carried by d D910A females were growth retarded and showed increased mortality in utero. Underpinning this fetal demise was a local inflammatory response characterized by increased abundance of MHC class II high expressing macrophages and IL-6. After birth, the surviving offspring displayed rapid catch-up growth. These findings demonstrate that maternal p110d signaling is required for reproductive fitness and stress the importance of correct immune regulation during gestation. 
RESULTS

Maternal PI3K p110d Inactivation Affects IFN-g Production In Utero
In mice, uNK cell-derived IFN-g is key for the vascular changes the gravid uterus needs to undergo to ensure ample and constant blood supply to the fetoplacental unit (Ashkar and Croy, 2001; Ashkar et al., 2000; Kieckbusch et al., 2014) . We and others have previously shown that PI3K p110d regulates NK cell development, function, and trafficking (Guo et al., 2008; Kim et al., 2007; Saudemont et al., 2009; Tassi et al., 2007) . The role of this isoform in reproductive immunology, however, has not yet been well characterized.
NK cells from d D910A mice are known to have a reduced migratory potential to the pregnant uterus in a competition situation with wild-type NK cells (Saudemont et al., 2009 ). We therefore hypothesized that there may be NK cell abnormalities in d
D910A
mice that could underpin pregnancy complications and set out to investigate the effect of p110d inactivation in this context. d D910A females displayed reduced overall cellularity during pregnancy ( Figure 1A ), but the abundance of NK1. Figures 1B and 1C) . Recently, NK cells found in peripheral tissues, including the uterus, have been distinguished into ''tissue resident'' and ''conventional'' NK (cNK) cells, which migrate to these organs (Sojka et al., 2014 (Barber and Pollard, 2003) and produce >90% of IFN-g in uterine tissues, and this cytokine is both necessary and sufficient to induce complete vascular remodeling Croy, 1999, 2001; Ashkar et al., 2000) .
Reduced activation of uNK cell subsets leads to decreased uNK IFN-g production (Kieckbusch et al., 2014) , and the PI3K p110d/Akt pathway is known to be crucial for the normal release of IFN-g by NK cells (Guo et al., 2008; Kim et al., 2007) . In line with this reported evidence for peripheral NK cells, we found a marked reduction of IFN-g in decidua and MLAp (myometrial lymphoid aggregate of pregnancy) by >35% ( Figure 1F ; 233.6 pg/g ± 14.79 versus 145 pg/g ± 8.24). We found no difference in Il15 expression by non-hematopoietic cells at the maternal fetal interface ( Figure 1G ). The uNK cell maturation profile differs from that of peripheral NK cells (Kieckbusch et al., 2014) , and insufficient maturation might underpin reduced levels of tissue IFN-g. However, we could not find absence of uNK cell maturation in d D910A females ( Figure S1 ). PI3K p110d is known to be important for T and B cell development and function (Bilancio et al., 2006; Okkenhaug et al., 2002; Patton et al., 2006; Putz et al., 2012; Soond et al., 2010) . No difference in the cellularity of any lymphocyte subset investigated was found ( Figure S2 ). To investigate the possibility of an NK defect in these mice further, we extended our evaluation to non-pregnant mice. While we found no difference in the overall size of the NK compartment ( Figure 1H ), CD49a + NK were overrepresented in non-pregnant d D910A mice ( Figure 1I ). Lack of p110d signaling did not affect the potential of either uNK cell subset to proliferate, as both displayed indistinguishable levels of Ki-67 positivity (Figures 1J and 1K) . Together, these data demonstrate the importance of PI3K p110d in uNK cell IFN-g production but show that its function is dispensable for maintaining normal uterine lymphocyte cellularity during pregnancy.
Maternal p110d Inactivation Impedes Normal Decidualization and Arterial Remodeling
In mice, decidualization is accompanied by the establishment of a highly organized lymphoid structure adjacent to the decidua (MLAp) and distal to the invading trophoblast. Both decidualization and MLAp growth are impaired in the absence of uNK cells (Ashkar and Croy, 2001; Barber and Pollard, 2003; Guimond et al., 1997) . Visual examination of H&E-treated sections showed both smaller decidual and MLAp areas on midsagittal uterine sections, indicating impaired decidualization and myometrial abnormalities in d D910A females (Figure 2A) . Quantification of the volumes of both compartments showed a reduction in size ( Figures  2B and 2C ), which correlated with the observed reduced overall cellularity ( Figure 1A) . Strikingly, implantation sites from d D910A females also displayed a marked reduction in vessel size ( Figure 2D ) and in the ratio between vessel and lumen areas, which is a measure of arterial remodeling ( Figure 2E ). Both are NK cell-driven processes mediated by IFN-g (Ashkar et al., 2000) . This was confirmed by visualizing smooth muscle actin in the decidua (Figure 2F) . While the thick muscle wall surrounding the spiral arteries had almost completely disappeared in controls, it was still prominent in d D910A females at gestational day 9.5 (gd9.5). To ascertain that this phenotype was leukocyte-specific, we evaluated expression of the pik3cd gene (which codes for p110d) in non-hematopoietic cells at the maternal-fetal interface. CD45 -cells showed very low levels of transcripts close to the detection threshold and comparable to those in the mouse fibroblast cell line NIH 3T3 ( Figure 2G ) that was used as a negative control due to its reported low pik3cd expression (Kok et al., 2009) .
Taken together, these results demonstrate that maternal p110d signaling in leukocytes is important for normal decidual and myometrial development during pregnancy and that it is essential for arterial remodeling and a normal blood supply to the fetoplacental unit.
Maternal p110d Is Required for Normal Fetal Growth
Next, we investigated the downstream effects of the suboptimal intrauterine environment on the developing fetuses. Fetuses carried by d D910A females showed significantly lower weights, which was detectable as early as gd14.5. This reduction in fetal growth resulted in offspring that was >13% smaller than in control pregnancies just before term (1.227 g ± 0.006 g versus 1.064 g ± 0.015 g at gd18.5). Reduction of mean fetal weight at gd18.5 was due to differences in weight distribution ( Figure 3B ). Strikingly, there was a >15-fold increase in growth-retarded fetuses defined as within or below the fifth percentile of B6 controls (Figure 3C) . Placental growth was very similar in conceptuses from d D910A females and B6 controls apart from a subtle increase in placental weight at gd16.5 ( Figure 3D ). Accordingly, absence of maternal p110d signaling lead to a reduction in the capacity of placentas of similar size to support the same fetal growth, suggesting reduced placental efficiency throughout gestation ( Figure 3E ). )F1). Figure 3F shows that isogenic heterozygous fetuses (d D910A/WT ) showed different fetal weights at gd18.5 that depended on whether or not maternal PI3K p110d signaling was absent, thus strongly suggesting a maternal rather than a fetal phenotype in these matings. Potential gene dose effects may also affect the placenta, which has the same genotype as its fetus. To this end, histological examination showed no overt differences in the fetomaternal exchange area (labyrinth zone, Figures 3G and 3H ), but a slight increase in the size of the junctional zone that borders this area was observed (data not shown). To exclude differences in maternal nutrient allocation that might affect fetal growth in d D910A mothers, we also assessed the availability of soluble factors in maternal serum. We found a subtle decrease in non-fasting glucose levels at the end of gestation that was pregnancy specific, as we found non-pregnant d D910A to have slightly elevated glucose levels ( Figure 3I ). No significant differences were observed in the levels of triglycerides or cholesterol (data not shown). Taken together, these data show that maternal p110d is crucial for normal fetal growth in utero.
Fetal Death and Accelerated Postpartum Growth in the Absence of Maternal p110d Signaling
To further investigate the effect of maternal p110d inactivation on reproductive success, we assessed the litter sizes from d D910A females ( Figure 4A ). versus 5 ± 0.38 in d D910A females), further emphasizing the detrimental effect of maternal p110d inactivation for fetal wellbeing. Litter sizes in the reverse cross were normal, demonstrating that absence of maternal p110d signaling, rather than a fetal effect of the heterozygous d D910A mutation, was responsible for this (Figure 4B) . Importantly, Rag2
) mice that lack all lymphocytes including NK cells show a reduction in fetal growth (Croy et al., 2011; Kieckbusch et al., 2014) but no decrease in the number of viable implantation sites ( Figure 4B ). This suggested that while the defect in NK cells described here may be sufficient to explain the reduction in fetal weight and arterial remodeling, it was likely that other, non-lymphoid cells were also affected by maternal p110d inactivation and contributed to the fetal demise.
Low birth weight predisposes to adult diseases such as metabolic disease, cardiovascular disease, and cancer (Barker, 2004) . Excessive growth postpartum (''catch-up'' growth) following fetal growth restriction is associated with additional risk factors, including decreased cognitive functions and short lifespan (Fisher et al., 2006; Geiger et al., 2012; Ozanne and Hales, 2004) . To investigate if maternal p110d inactivation might contribute to this increased risk, we followed the growth trajectory of (d D910A 3 B6)F1 and (B6 3 d D910A )F1 offspring.
Pup weights from both crosses were indistinguishable starting from postpartum day 7 (pp7) ( Figure 4C ; data not shown), demonstrating accelerated growth in the sensitive postnatal period. In order to assess if the observed phenotype was restricted to primiparous females, we obtained breeding records from two animal facilities ( Figures 4D, 4E , and S3). We found that maternal p110d signaling was essential for normal litter sizes regardless of parity. This finding was reproduced also in OT-II Rag2
mice which lack B cells and are incapable of generating fetalspecific T cells ( Figure 4F ), suggesting that dysregulation in these cells does not contribute to increased fetal loss. Together, these data show that maternal p110d inactivation affects fetal well-being. 
Maternal p110d Signaling Prevents Uterine Inflammation
As the NK phenotype could explain differences in fetal growth, but not in litter size, we extended our focus to myeloid cells. A gating strategy adapted from Tagliani et al. (2011) was used to identify macrophages, neutrophils, Ly6C high monocytes (a precursor to uterine macrophages), and dendritic cells (DCs) (which are recruited to the uterus by uterine macrophages; Figure 5A ). We found that all myeloid subsets except neutrophils were significantly underrepresented during pregnancy ( Figure 5B ). Using immunohistochemistry, we confirmed that the abundance of F4/80 + was indeed lower in both decidua and MLAp of d D910A females around midgestation ( Figure 5C ).
Uterine macrophages can be grouped into two subsets based on their expression of MHC class II (Tagliani et al., 2011) : a subset that expresses low levels of MHC class II (MHC-II low ), which has been reported to have higher mRNA levels of genes associated with alternatively activated (M2) macrophages, and a second subset that expresses high levels of MHC class II (MHC-II high ) and has a transcription profile of genes more associated with the M1 type of macrophages. Given the striking reduction in macrophage abundance, we investigated their phenotype further. In d D910A females, the MHC-II high subset was relatively overrepresented among macrophages ( Figures  5D and 5E ), suggesting an imbalance toward a more inflammatory uterine milieu in these mice during pregnancy. In contrast, no subset imbalance was seen for DCs (CD11b high versus CD11b low ) or monocytes (MHC-II + versus MHC-II À ; Figures 5F and 5G). Apart from IFN-g, uNK cells can also produce other immunomodulatory factors, including CSF-1, a key cytokine for uterine macrophage population dynamics, so that unbalanced uNK activation could potentially be responsible for the macrophage phenotype. To explore this possibility, we assessed the expression of csf1 and ccl5 (whose gene product is RANTES that could regulate uNK cell migration). For csf1, we found the highest relative amount of mRNA in non-hematopoietic cells, but at similar levels in both strains across cell types ( Figure 5H ). Expression of Ccl5 was also similar between strains, but uNK cells had higher expression than CD45 À cells ( Figure 5I ). To further investigate a possible regulatory role of uNK or other lymphoid cells on macrophages, we also assessed the phenotype of myeloid cells in Rag2 À/À gc À/À mice which showed neither disruption of macrophage numbers nor reduction in DC or monocytes despite the total absence of NK cells ( Figures 5J  and 5K ). We did, however, find increased numbers of uterine neutrophils, thus excluding the possibility that an increase of these cells by itself can cause fetal loss. Together, these results demonstrate changes in uterine myeloid cells including a more inflammatory macrophage phenotype in the absence of p110d signaling. The results also suggest that these changes are not due to NK cell dysregulation.
Local, but Not Systemic, Inflammation Underpins Fetal Growth Restriction and Increased Fetal Mortality
The PI3K pathway is known to be important for the resolution of inflammation mediated by myeloid cells (G€ unzl et al., 2010) , and the p110d subunit of PI3K has been shown to induce a negative feedback mechanism that dampens macrophage activation downstream of Toll-like receptors (Aksoy et al., 2012) . The overrepresentation of MHC-II high macrophages raised the question as to whether an increased inflammatory response could be responsible for the increase in fetal loss. To test whether changes in the relative abundance of macrophage subsets translate into a more potent inflammatory response, we assessed macrophage effector functions (IL-6 production and CD107a surface exposure as a proxy for degranulation). Macrophages in d D910A mice showed a significantly higher responsiveness even after overnight culture ( Figures 6A and  6B ). IL-6 has been reported to be involved in fetal loss (Zenclussen et al., 2003) , and following its increased production by uterine macrophages in the absence of p110d signaling, we wanted to directly assess whether this correlated with overall higher levels of this cytokine in decidua and myometrium. We found a significant increase in IL-6 levels in situ ( Figure 6C ), but no change in IL-10 ( Figure 6D ), which is associated with an anti-inflammatory response. Tissue levels of tumor necrosis factor (TNF) and IL-1b were below the detection threshold in both strains (data not shown). Together, these results show a dysregulation of macrophage dynamics and function that was associated with upregulation of IL-6, suggesting a more inflammatory intrauterine environment. we tested if the inflammatory phenotype observed in utero was only seen in the local environment or due to possible systemic inflammation and unrelated to pregnancy. To this end, we found similar serum levels of IL-6, TNF, and IL-10 in the second half of gestation, clearly showing that the inflammatory uterine milieu is restricted locally and not associated with acute systemic inflammation during pregnancy ( Figure 6 ). We did find increased IL-6 levels in one out of six females at gd14.5 and one out of seven females at gd18.5. However, these did not correlate with increases in TNF, and in order to be causally linked to the phenotype described here, we would expect all females to show increases in IL-6 at the end of gestation (gd18.5). We also assessed serum IL-1b with very low overall abundance and a similar number of samples below the detection threshold of 0.3 pg/ml in both strains (data not shown). Progesterone withdrawal is a potent inducer of fetal loss (Yang et al., 2000) . Lastly, to investigate whether reduced progesterone levels might contribute to the phenotype in d D910A females, we evaluated the levels of this hormone in the serum late in gestation. We found no evidence for a reduction in progesterone due to p110d inactivation but instead found a small but significant increase ( Figure 6H ). Together, these data show a heightened inflammatory environment in utero in the absence of systemic inflammation or progesterone dysregulation.
DISCUSSION
Little is known about the mechanisms that orchestrate the dynamic changes that uterine innate immune cells undergo during gestation. Our results identify a key role for maternal PI3K p110d signaling in the immune regulation during pregnancy. This isoform is absent in most tissues but highly expressed in leukocytes (Vanhaesebroeck et al., 1997) . Due to its function in many immune cells and the importance of leukocytes for successful pregnancy, the mechanisms by which p110d signaling impacts reproductive success are multifactorial. Maternal p110d inactivation affected the outcome of pregnancy through two pathways: one mediated by poor uNK function leading to reduced arterial remodeling and fetal growth restriction and one characterized by a heightened inflammatory uterine milieu underpinning increased fetal mortality ( Figure S4 ). PI3K p110d has been implicated in smaller litter sizes in a previous study using knockout mice on a 129 background (Li et al., 2013) . In that study, the authors suggested that this was due to differences in ovarian hormone responsiveness of these pik3cd À/À mice. The study of class IA PI3K is complicated by the fact that the absence of one subunit affects the expression levels of other subunits (Okkenhaug and Vanhaesebroeck, 2001) , which is not the case for the kinase-dead mutation in d D910A mice (Okkenhaug et al., 2002 ).
Our results demonstrate that maternal p110d does not alter the amount of implanted blastocysts that gestate to midpregnancy but rather fetal growth and survival after this time point. In non-pregnant mice, we found an overrepresentation of CD49a + uNK cells. Based on our previous work that showed suggest that compensatory mechanisms other than overt differences in proliferation or migration are in place that lead to similar uNK cell abundance in both strains. While we were unable to detect a clear difference in the uterine lymphocyte profile of d D910A mice during pregnancy, we did notice an overall higher variance in some leukocyte subsets compared to B6 controls (e.g., T cells in Figure S2 and neutrophils in Figure 5B ). The reason for this is unclear, but it might be due to the fact that the results are generated by pooling implantation sites from individual mice, in which the observed phenotype may be at different stages. Another factor is that we used pooled cell suspensions from decidua and myometrium (MLAp) to evaluate overall leukocyte dynamics in utero. This might obscure smaller differences that occur in one compartment, but not in the other, especially given their known differences in leukocyte composition (Doisne et al., 2015; Tagliani et al., 2011) . PI3K p110d has a critical role for B and T cell function, including regulatory T (Treg) cells (Ali et al., 2014; Liu et al., 2009; Okkenhaug et al., 2002; Patton et al., 2006) , and it is thus possible that Treg cells are less effective at controlling effector responses in the uterus of d D910A mice. While fetal loss in d D910A females mated with syngeneic males was independent of adaptive B or T cells capable of responding to fetal antigens, we would hypothesize that p110d inactivation in allogeneic matings may be even more detrimental to fetal survival, as Treg function is crucial in this setting (Rowe et al., 2012; Samstein et al., 2012) . CSF-1 is a key player for orchestrating distribution and population dynamics of macrophages as well as DCs in utero, and mice lacking CSF-1 show mildly reduced litter sizes (Pollard et al., 1991; Tagliani et al., 2011) . High MHC class II expression in macrophages correlates with a transcription profile of classically activated (M1) cells that are associated with inflammatory responses, whereas low class II expression is found on cells that express genes observed in alternatively activated macrophages (M2 group) that are involved in tissue remodeling and angiogenesis (Murray et al., 2014) . The conversion of these M2-like cells to M1-like cells is normally blocked by CSF-1 signaling. Because p110d is the dominant PI3K isoform downstream of CSF-1 receptor in primary macrophages (Papakonstanti et al., 2008) , it is conceivable that dampened CSF-1 signaling may contribute to the altered macrophage dynamics and the relative abundance of cells highly expressing MHC class II in d D910A mice. It has been speculated that MHC-II high and MHC-II low subsets resemble CD209 À and CD209 + macrophage subsets found in first trimester human endometrium based on similarities in gene expression (Erlebacher, 2013) . In macrophages and other myeloid cells, p110d signaling is known to be crucial for the resolution of inflammation (Aksoy et al., 2012; Fukao and Koyasu, 2003; G€ unzl et al., 2010; Liu et al., 2009; Uno et al., 2010) . This might explain the relative overrepresentation of macrophages with a more inflammatory phenotype; these cells need to receive their physiological cues in utero to function correctly. In the absence of p110d signaling, this activation becomes dysregulated, and instead of switching to their physiolog- ical role in tissue remodeling, macrophages sustain persistent inflammation.
Excessive immune activation has long been known to compromise pregnancy success and activation of the innate immune system by pathogen-derived danger signals can jeopardize fetal survival (Parant and Chedid, 1964; Xu et al., 2000) . Although the underlying mechanisms are still not fully understood, it seems clear that the tissue damage mediated by infiltrating neutrophils and activated macrophages is not conducive to a uterine microenvironment capable of promoting adequate fetal growth. Pregnancy is not accompanied by general immunosuppression (Kourtis et al., 2014) , however, and it is becoming increasingly clear that successful pregnancies involve a fine balance between activating those parts of the immune system involved in trophic functions (uNK-mediated arterial remodeling, macrophage involvement in tissue remodeling) and those components that are involved in host defense . To this end, great care must be taken when it comes to clinical interventions with the aim of interfering with immune responses during gestation, as the spatiotemporal role of each leukocyte subset is far from understood.
Isoform-specific small molecule inhibitors for p110d are now in clinical trials. d D910A mice model long-term p110d inhibition, and our results suggest that such long-term inhibition may best be avoided during pregnancy. The traditional model for inflammation-mediated fetal demise is injection with Toll-like receptor agonists such as poly(I:C) or lipopolysaccharide. This also triggers systemic immune system activation (Cotechini et al., 2014; Thaxton et al., 2013; Zhao et al., 2015) . In our study, we observed local and spontaneous inflammation in utero with physiological levels of inflammatory cytokines in the periphery throughout gestation. This suggests that d D910A mice are indeed a good model to study the effects of uterine inflammation during pregnancy in greater detail, as it allows for complete dissociation of systemic and local inflammation. In conclusion, our results emphasize the complexity of maternal immune responses during pregnancy. This strengthens the notion that clinical interventions with the aim of dampening maternal immune responses do not have a scientific basis (Moffett and . Rather, multiple leukocyte subsets need to exert their functions in a balanced way.
EXPERIMENTAL PROCEDURES Mice
All animal experiments were approved by the University of Cambridge Ethical Review Panel and carried out in accordance with Home Office Project License PPL 70-8222. C57BL/6 (B6) mice were purchased from Charles River UK. Mice with a kinase-dead mutation in the gene coding for PI3K p110d (d D910A ) have been described before (Okkenhaug et al., 2002) and were backcrossed on a B6 background for >12 generations. OT-II Rag2 À/À d D910A (Ali et al., 2014) and alymphoid Rag2
) (Colucci et al., 1999 ) mice on B6 background have been described before. Mice were 8-12 weeks of age and showed no signs of colitis. For pregnancy experiments, female mice were randomly introduced to males and the timing of conception was determined by detection of a copulation plug representing gd0.5.
Flow Cytometry
Cell suspensions of uterine tissues were prepared using either mechanical dissociation followed by centrifugation through a Lympholyte M (Cedarlane) gradient according to the manufacturers recommendations or by enzymatic digestion using Liberase TM (Roche) as described previously (Collins et al., 2009 ). Cells were typed using fluorochrome-conjugated antibodies with specificity for CD45 (30-F11), NK1.1 (PK138), CD11b (M1/70), CD27 (LG.3A10), CD49a (HMa1), CD49b (DX5), KLRG1 (MAFA), Ly6C (HK1.4), Gr-1 (RB6-8C5), I-A/I-E (M5/114.15.2), F4/80 (BM8), CD11c (N418), CD3ε (145-2C11), CD4 (GK1.5), CD8a (53-6.7), CD19 (1D3), CD122 (5H4), NKp46 (29A1.4), IL-6 (MP5-20F3), CD107a (1D4B), and Ki-67 (B56) purchased from BD PharMingen, BioLegend, or eBioscience. For intracellular and intranuclear antigens, Fix & Perm and Foxp3 staining buffer set (both eBioscience) were used, respectively. For estimation of total cell number and leukocyte composition, enzymatic digestion was preferred as it yielded higher amounts of non-lymphocytes and did not exclude cells based on size or density. For phenotyping of NK cells, mechanical dissociation followed by Lympholyte M was used in order to prevent degradation of surface proteins. In Vitro Culture Single-cell suspensions from gd10.5 pregnant females were prepared by Liberase TM digestion and incubated in complete RPMI cell culture media for 2 hr. Non-adherent cells were removed and cells cultured overnight in fresh complete RPMI with brefeldin A (eBioscience) and monensin present for the final 4 hr.
qRT-PCR
Histology
Rat-anti mouse F4/80 was used at 1/100 (C1:A3-1, Ab Serotec) after proteinase K antigen retrieval and visualized using the ImmPress kit (Vector). Smooth muscle actin (DAKO 1A4) staining was performed after heat-induced antigen retrieval in citrate buffer using a 1/100 dilution according the instructions of the mouse-on-mouse immunodetection kit (Vector). Histological examination of H&E stains for overt placental abnormalities was performed at gd18.5 by determining the area of the labyrinth zone on midsagittal sections through the placenta. All histology was carried out on formalin-fixed paraffin-embedded tissue.
Stereology
Tissue volume estimation using the Cavalieri method and assessment of spiral artery remodeling was performed using H&E-stained sections as described previously .
Cytokine Quantification in Tissue Lysates
Myometrial and decidual tissue from gd10.5 pregnant females was snap frozen on dry ice and the whole litter pooled. 150 mg tissue was added to 1 ml lysis buffer (150 mM NaCl, 20 mM Tris, 1 mM EGTA, 1% Triton X-100, 1/100 Phosphatase Inhibitor Cocktail 3 [Sigma], 1/100 Phosphatase Inhibitor II [Sigma] , 23 Ultra Protease Inhibitor solution [Roche] , and 2 mM PMSF) and processed with a tissue homogenizer on ice. The homogenate was incubated on ice with agitation for 30 min and spun at 20,000 3 g for 10 min. The supernatant was used for further analysis on the MesoScale Ultra Sensitive platform. Total protein concentration was determined using a Bradford assay (Pierce).
Blood and Serum Measurements
Non-fasting blood samples were taken immediately after cervical dislocation from the aorta. Blood glucose was measured immediately using a digital glucometer. Samples were centrifuged at 12,000 3 g for 5 min and supernatant stored at À80 C before being used for MesoScale Ultra Sensitive assays.
Statistics
Normally distributed, independent, and unmatched data were analyzed with two-tailed, unpaired Student's t tests. Data clustered by litter (fetal/placental weights, arterial remodeling) that violate the assumption of independence of data points were analyzed using a mixed-model approach taking the fixed effect of parental cross and the random effect of litter variability into account (Barber and Pollard, 2003; Kieckbusch et al., 2014) . Categorical data were analyzed using Fisher's exact test. p < 0.05 was taken as statistically significant for all tests. Analyses were performed using GraphPad Prism, GraphPad Quick Calcs, and IBM SPSS. 
SUPPLEMENTAL INFORMATION
